Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02315079 · ClinicalTrials.gov registry record
Point of Care Testing of Inflammatory Markers in Tears
A clinical trial, sponsored by University of Florida.
- Completed
- Registry status
- 63
- Enrollment target
NCT02315079 is a clinical trial that has completed, run by University of Florida. The registered enrollment target is 63 participants.
The verdict
NCT02315079 has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
To evaluate the use of a point of care device to measure markers of inflammation in various eye conditions. In particular, matrix metalloproteinase-9 (MMP-9) will be measured. MMP-9 is an enzyme that plays a role in inflammation. The value obtained with the point of care device will be correlated with values obtained using gel electrophoresis to measure MMP-9 from the same sample. These data will be compared to clinical exam findings and questionnaires to help the investigators better understand the role of this marker of inflammation in eye diseases and possibly improve diagnostic abilities.
Interventions
- OTHER Eye inflammation
- OTHER Without eye inflammation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2015-01 |
| Est. Completion | 2017-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02315079
The ClinicalTrials.gov registry entry for NCT02315079 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Eye inflammation is the first listed.
NCT02315079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02315079 about?
NCT02315079 is a clinical study titled "Point of Care Testing of Inflammatory Markers in Tears". To evaluate the use of a point of care device to measure markers of inflammation in various eye conditions. In particular, matrix metalloproteinase-9 (MMP-9) will be measured. MMP-9 is an enzyme that plays a role in inflammation. The value obtained with the point of care device will be correlated wi...
What is the current status of trial NCT02315079?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2015-01. Estimated completion is 2017-01.
What interventions are being tested in trial NCT02315079?
The interventions under investigation include: Eye inflammation (OTHER), Without eye inflammation (OTHER).
Who is sponsoring clinical trial NCT02315079?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.